Menu
GWAS Study

Genome-wide association of lipid-lowering response to statins in combined study populations.

Barber MJ, Mangravite LM, Hyde CL et al.

20339536 PubMed ID
GWAS Study Type
3928 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BM
Barber MJ
ML
Mangravite LM
HC
Hyde CL
CD
Chasman DI
SJ
Smith JD
MC
McCarty CA
LX
Li X
WR
Wilke RA
RM
Rieder MJ
WP
Williams PT
RP
Ridker PM
CA
Chatterjee A
RJ
Rotter JI
ND
Nickerson DA
SM
Stephens M
KR
Krauss RM
Chapter II

Abstract

Summary of the research findings

Statins effectively lower total and plasma LDL-cholesterol, but the magnitude of decrease varies among individuals. To identify single nucleotide polymorphisms (SNPs) contributing to this variation, we performed a combined analysis of genome-wide association (GWA) results from three trials of statin efficacy.

3,928 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

3928
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.